 |
 |
Epidemiology and Genetics Research Program
Division of Cancer Control and Population Sciences
October 27, 2005 |
EGRP BULLETIN
From the Office of
Edward Trapido, Sc.D., Associate Director
Epidemiology and Genetics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
This issue of NCI's Epidemiology and Genetics Research Program (EGRP)
Bulletin brings you news about:
EGRP Will Be At AACR Frontiers in Cancer Prevention Conference
| EGRP will be attending the American
Association for Cancer Research (AACR) Frontiers in Cancer Prevention
Research Conference on October 31 – November 2, Baltimore,
Md. If you are attending, you are welcome to contact staff in advance
to make arrangements to meet. In addition, drop by and visit EGRP’s
exhibit (booth L) and a poster by some of our staff titled “Trends
and Developments in Consortia as Tools for Genetic Epidemiology
Research.” |
|
| |
 |
Attending from the Office of the Associate Director are:
From the Analytic Epidemiology Research Branch (AERB):
- Mukesh Verma, Ph.D.,
Acting Chief; and
- Virginia (Ginny) Hartmuller, Ph.D., R.D., Program Director.
(Ginny is moving households immediately before the meeting so,
please, leave a voice mail message for her at 301-594-3402.)
From the Clinical and Genetic Epidemiology Research Branch (CGERB):
- Emily Dowling,
M.H.S., Associate Coordinator, Breast and Colon Cancer Family
Registries, and Cancer Research Training Award Fellow;
- Isis Mikhail, M.D.,
M.P.H., Dr.P.H , Program Director;
- Daniela Seminara, Ph.D., M.P.H., Program Director; and
- Scott Rogers, M.P.H.,
Research Associate.
|
The poster on consortia as tools for genetic epidemiology research is
by Scott Rogers, Emily Dowling, Carmina Valle, Isis Mikhail, and Daniela
Seminar. It is scheduled for bright and early Wednesday morning, November
2, from 7:30-9:15 a.m. in Exhibit Hall E (Poster Session C). Come join
us.
EGRP Grantees Moscicki and Carroll Receive NCI MERIT Awards
  We
are delighted to announce that EGRP-supported grantees Anna-Barbara
Moscicki, M.D.,
Professor of Pediatrics and Associate Director for Adolescent Medicine,
University of California at San Francisco, and Raymond Carroll,
Ph.D., Distinguished Professor of Statistics at Texas A&M
University, recently received NCI Method to Extend Research in Time (MERIT)
Awards, which provide them each an additional 5 years of funding for
their research. MERIT Awards are given to investigators who have Research
Project Grants (R01), whose competence and productivity are distinctly
superior, and who are likely to continue to perform in an outstanding
manner. Recipients are nominated by NCI staff and approved by the National
Cancer Advisory Board.
Dr. Moscicki received the award to continue her research
on the natural history of human papillomavirus (HPV) infection in adolescents
and young women. Her research is from a cohort study on HPV infection
in the San Francisco area which EGRP first funded in 1990. The study
is one of the oldest and most productive molecular epidemiological investigations
of the natural history of HPV and cervical cancer. Dr. Moscicki’s
findings on high rates of regression of low-grade squamous intraepithelial
lesions (LSIL) influenced the new American Cancer Society guidelines
for when to start screening for cervical cancer and the new guidelines
of the American Society for Colposcopy and Cervical Pathology for LSIL
management in adolescents.
She and her research team were one of the first to show that the majority
of young women clear HPV and that persistence of HPV is a strong risk
for the development of high-grade squamous intraepithelial lesions (HSIL).
She also was one of the first investigators to find that self-sampling
may be an accurate and noninvasive method for obtaining HPV DNA samples.
Other findings by the group suggest that cytotoxic T-lymphocyte (CTL)
responses to the HPV 16 E6 antigen appear to be important in maintaining
viral clearance and, consequently, the antigen may be important in designing
therapeutic vaccines.
Dr. Moscicki is Board Certified in Pediatrics and Adolescent Medicine.
Vaurice Starks, AERB, is Program Director for Dr. Moscicki’s grant.
Dr. Carroll received the award to continue his research
to develop statistical methods applied to problems involving cancer and
nutrition, particularly colon and breast cancer. Through his current
grant, Dr. Carroll has made fundamental contributions to understanding
the statistical properties of instruments for measuring dietary intake,
including the food frequency questionnaire, 24-hour recalls, and multiple-day
food records. These instruments all measure nutrient intake with uncertainty,
also called measurement error, and his seminal contribution to the statistical
analysis of epidemiological data when exposures are measured with uncertainty
are well recognized and resulted in the publication of a well-cited book.
In addition to his work in nutritional epidemiology, Dr. Carroll works
in the analysis of basic biological experiments, where the aim is to
see whether dietary mediation can affect cellular response to environmental
carcinogens and radiation. His work here, which falls into a framework
that statisticians call hierarchical functional data analysis, won numerous
awards in the current grant period, and the new statistical methods that
he has pioneered have helped in our understanding of how stem cells,
proliferating cells, and fully differentiated cells respond to carcinogen/radiation
exposure, and how this response is affected by diet.
He is a Fellow of the American Statistical Association, Institute of
Mathematical Statistics, and International Statistical Institute, and
past editor of the Journal of the American Statistical Association and Biometrics.
During the current grant period, he was named the Fisher Lecturer by
the major North American statistical societies, the most prestigious
senior honor in statistics, reserved for those who have changed the theory
and practice of the field.
EGRP Grantee Olopade Receives MacArthur Foundation “Genius
Grant”
 EGRP
grantee Olufunmilayo (Funmi) Falusi Olopade, M.D., of the University
of Chicago, received one of this year’s fellowships awarded by
the John D. and Catherine T. MacArthur Foundation. The awards recognize
talented individuals who have shown extraordinary originality and dedication
in their creative pursuits and a marked capacity for self-direction.
Dr. Olopade will receive $500,000 in "no strings attached" support
over the next five years.
Dr. Olopade was selected for "translating findings on the molecular
genetics of breast cancer in African and African-American women into
innovative clinical practices in the United States and abroad.” She
is Professor in Medicine and Human Genetics and Director of the Cancer
Risk Clinic at the University of Chicago Hospitals.
With EGRP funding, Dr. Olopade is conducting an epidemiologic study
to determine the role of BRCA1 and BRCA2 gene mutations
in breast cancer risk among premenopausal African-American and African
women. Women of African ancestry are at greater risk for mortality due
to breast cancer than other racial/ethnic groups for reasons that are
unknown, and little is known about their risk for the cancer in relation
to BRCA1/2. She is studying premenopausal African-American women
who are enrolled in the Northern California Cancer Center component of
the Breast Cancer Family Registry (B-CFR) and African women recruited
through the University College Hospital, Ibadan, Nigeria. The women are
enrolled because of a family history of breast or ovarian cancer or because
they have had bilateral breast cancer. This study will lead to more accurate
definition of genetic risks, improved clinical risk assessment, and potentially
to development of new prevention, early detection, and treatment strategies
for young women of African ancestry.
In addition, Dr. Olopade is a member of the Steering Committee for the
B-CFR, a research resource for investigators that is funded by EGRP, and
is co-investigator for a specialized center grant (P50) as part of the
Centers for Population Health and Health Disparities initiative. Funded
through our Division of Cancer Control and Population Sciences’ (DCCPS)
Behaviorial Research Program (BRP), these centers support transdisciplinary
research leading to an understanding and reduction of health disparities
in domestic populations.
Funding Opportunities
RFA Issued for Research on Environmental Influences
on Epigenetic Regulation
EGRP is cosponsoring a Request for Applications (RFA) on Environmental Influences
on Epigenetic Regulation. Applications are sought that examine epigenetic
changes as a part of the mechanisms of action of environmental agents in
the etiology, prevention, or progression of disease dysfunction. Applicants
may use in
vitro systems, eukaryotic animal models, or human specimens. The total
amount to be awarded is $3.75 million. The anticipated number of awards
is 8-12. The initiative uses the exploratory/development (R21) and investigator-initiated
research project (R01) grants mechanisms. The RFA is cosponsored with the
National Institute of Environmental Health Sciences (NIEHS) and NCI’s
Division of Cancer Prevention (DCP).
 Letters of intent are due December 19, 2005, and applications are due January
18, 2006.
The EGRP contact is Mukesh Verma, Ph.D., Acting Chief, Analytic Epidemiology
Research Branch (AERB), tel.: 301-594-7344; e-mail: vermam@mail.nih.gov.
The DCP contact is Sharon Ross, Ph.D., M.P.H., tel.: 301-594-7547; e-mail: rosssha@mail.nih.gov;
and the NIEHS contacts are Frederick Tyson, Ph.D., tel.: 919-541-0176; e-mail: tyson2@niehs.nih.gov;
and Jerry Heindel, Ph.D., tel.: 919-541-0781; e-mail: heindelj@niehs.nih.gov.
See the NIH Guide for Grants and Contracts (RFA-ES-05-007).
RFP Issued for Cancer Genetics Network
NCI has issued a Request for Proposals (RFP) for a Data
Coordinating Center to manage the Cancer Genetics Network (CGN) that will
provide data coordinating services and manage subcontracts for up to 15 individual
CGN Centers. The link to the Statement of Work is in Section III, page
24, of the solicitation. From the Statement of Work:
NCI “requires maintenance of the Cancer Genetics Network (CGN) which
has over 24,000 enrollees in its recruitment pool, representing more
than 16,000 families on whom the following data have been collected: cancer
type if present, a four generation cancer family history, genetic testing
(if performed), genetic mutation if collected in a CGN Special (Pilot)
Study, any known genetic syndromes in the family, biospecimens on many,
annual follow-up on all enrollees, tobacco history, and sociodemographic
information. Much more data have been collected on subsets of enrollees
who have participated in CGN Special Studies.
“The CGN grants started in the summer of 1998. There are eight CGN Participating
Centers and their seven associated sites where individuals are enrolled and
three informatics Centers comprising the Informatics Technology Group (ITG).
All CGN Centers and sites, will henceforth be referred to as the “Centers.” The
CGN has completed several Special Studies. Most of these have lead
to funded R01 applications.
“The Centers are now very experienced in translational, behavioral,
and basic science genetic studies, IRB application submissions, and
work well together as a group. The ITG has provided excellent statistical,
database, and software development support. The CGN has a multi-disciplinary
group of Principal Investigators who are experienced in collaborating with
outside investigators.
“The NCI wishes to maintain the integrity of the CGN enrollee pool
as well as the functions performed by the CGN which maintain that enrollee
pool and its annual followup.
“Maintaining the CGN database will permit investigators to obtain
access to existing data and biospecimens for use in cancer research studies
and provide interested investigators information about and access to
CGN study enrollees for studies/trials. Therefore, this funding mechanism
is being issued to meet the anticipated requirements of the CGN. Offerors
and their subcontractors must already have IRB approval to access (re-contact)
CGN enrollees and/or their data. This is a critical requirement for proposals
for this RFP.
“NCI is seeking a Data Coordinating Center (DCC) that will provide
data coordinating services and manage subcontracts for up to fifteen
(15) individual CGN Centers, (the 15 medical centers that currently make
up the Participating Centers and associated sites). Other sub-contractors
(OSCs) with IRB approval to access CGN enrollees and/or their data may
be proposed as the Offeror deems necessary.
“The major objective of this acquisition is to have a DCC aid in
maintaining the CGN enrollee database and research support for use thereof
in a high-quality, timely, and cost efficient manner. The associated objective
is to establish subcontracts with all approved CGN Centers to facilitate
their subcontractual requirements (see RFP). Proposed OSCs shall meet the
same requirements as the Centers for continued access to CGN enrollees
and/or their data.”
For further information, refer to RFP
NO1-PC-55049-40.
Proposals are due December 6, 2006. Direct inquiries to Ms. Dorothy McMillan,
Contracting Officer, Research Contracts Branch, NCI, tel.: 301-435-3828.
(Collect calls will not be accepted.)
EGRP Contact Changes for PA on Research on Malignancies in AIDS and
Acquired Immune Suppression
Please
note that we have updated our staff contacts for the Program Announcement
(PA) on Research on Malignances in AIDS and Acquired Immune Suppression.
Mukesh Verma, Ph.D., Acting Chief, AERB, replaces Dr. Sandra Melnick. His
contact information is tel.: 301-594-7344; e-mail: vermam@mail.nih.gov.
Vaurice Starks, AERB, continues to be a contact also, tel.: 301-402-7375; e-mail: starksv@mail.nih.gov.
NIH Guide Notice (NOT-CA-05-031)
Other On-Going EGRP-Sponsored PA/PARs
EGRP is sponsoring the following PA/PARs:
- Pilot
Studies in Pancreatic Cancer (PA-05-116) – Expires July
2, 2008, unless reissued.
- Small
Grants Program for Cancer Epidemiology (PAR-04-159) (Replaces
PAR-03-010) – This
reissued PAR is effective with November 21, 2006, receipt date. Note
new 10-page restriction on research plans including tables and figures.
- Studies
of Energy Balance and Cancer in Humans (PA-04-124) - Expires
November 2, 2006, unless reissued.
- Exfoliated
Cells, Bioactive Food Components, and Cancer (PA-04-114) - Expires
November 2, 2007, unless reissued.
- Occupational
Health and Safety Research (PA-04-038) - Expires November 23,
2006, unless reissued.
- Small Business Programs – Small Business Innovation Research (SBIR)
and Small Business Technology Transfer (STTR) Programs
- SBIR
Web page, and
- EGRP topics of interest
- Cohort
Studies in Cancer Epidemiology (PAR-04-011) - Expires November
2, 2005. This PA will not be reissued, which means that grant applications
for cohort studies in epidemiology may be submitted on the regular
grant cycle. Remember that NIH requires that grant applicants with
a requested budget over $500,000 in direct costs in any year of the
grant contact the appropriate program staff member to obtain approval
before submitting applications to the NIH Center for Scientific Review
(CSR) for peer review (NIH Guide: NOT-OD-02-004 and NOT-CA-04-004).
Approval for NCI epidemiology applications must be sought at least
8 weeks prior to submission to CSR to complete the internal processing
by the deadline. Investigators may be interested in knowing of the
cohorts currently
funded by EGRP.
NLM RFA Forthcoming
for Institutional Grants for Research Training in Biomedical Informatics
NIH’s National Library of Medicine
plans to issue a RFA for Institutional Grants for pre- and post-doctoral
research training in biomedical informatics in January 2006. Funding
decisions will be made by September or October 2006 to enable funded
sites to begin recruiting trainees for the 2007-2009 academic year.
Training will emphasize the preparation of individuals capable of carrying
out independent research in biomedical informatics, which is defined as
the intersection of basic informational and computing sciences with
a wide range of application domains in biomedicine. The Notice
of Intent appears in the NIH Guide (NOT-LM-05-011).
Grantsmanship
NIH Transitions To New Grant Application Form and Electronic Submission
of Applications
NIH is transitioning simultaneously from the PHS398 grant application to
the new SF424 Research and Related (R&R) application and electronic transmission
of submissions via Grants.gov. The
transition timeline is organized by type of grant program or funding mechanism
and begins in December 2005. If you are not immediately affected, take
advantage of this “heads up” to begin familiarizing yourself
with the new form and process.
The changes are part of the federal government’s initiative to simply
its financial assistance application requirements and create a single Web site – Grants.gov – through
which to identify and apply for grant opportunities.
With the December submission deadlines, the applications for the following
types of grants must use the new SF424 R&R application and be submitted
electronically:
- Small Business Innovation Research (SBIR) and Small Business Technology
Transfer Research (STTR) Programs (R41, R42, R43, R44) – December
1, 2005, (NOT-OD-05-068, PA-06-006, PA-06-007)
- Conferences and Scientific Meetings Support (R13, U13) – December
15, 2005.
The 2006 schedule is:
- Academic Research Enhancement Awards (AREA) (R15) – February 25,
2006,
- Small Grant Programs (R03) and Exploratory/Development Research Grant
Awards (R21, R23) – June 1, 2006
- Research Project Grant Program (R01) – October 1, 2006.
Before submitting applications online, applicant organizations must
be registered in both Grants.gov and in the NIH Electronic
Resource Administration (eRA) Commons. Apply
early; the process could take some time.
Notice of the transition plan and the above schedule appeared in the NIH
Guide (NOT-OD-05-067); release date, August 19, 2005. Effective dates
for other grant programs/mechanisms will be announced in the NIH Guide at
least 4-6 months in advance, with the transition to be completed by May 2007.
For further information, refer to:
NIH Small Business (SBIR and STTR) Programs Fast Track Changes
In addition to moving to electronic transmission of a new application
form, two major changes in submission and review of SBIR and STTR Programs’ Fast-Track
grant applications are effective with the December 1, 2005, receipt
date. The Fast-Track mechanism permits applicants to simultaneously submit
Phase I and II proposals for combined initial peer review and subsequent
program evaluation for phase II funding. The changes are:
- Fast-Track grant applicants now need to only prepare one grant application
package consisting of both Phase I and Phase II activities. In
the past, applicants were required to complete two separate and complete
applications, one each for Phase I and Phase II.
- The option for reviewers
to “decouple” the
Phase I/Phase II applications at the time of review will be eliminated.
In the past, not providing clear, measurable goals might have been sufficient
reason for the scientific review group to exclude the Phase II application
from Fast-Track review and evaluate the Phase I application only. A Fast-Track
application now will receive a single rating for the entire proposed project
(i.e., it will receive a numerical score or it will receive an “unscored” designation).
Thus, the entire proposed project is linked to its Phase I and
Phase II components, without benefit of potential separation.
For further information, see NIH Guide Notice (NOT-OD-06-004).
Register in the eRA Commons: NIH/EGRP Stops Sending Summary Statements,
Scores, and Notification Letters
 To comply with a Congressional mandate to move from paper-based to electronic
systems, NIH is ceasing to send summary statements and Peer Review Outcome
letters by postal mail or electronic mail to Principal Investigators. As
of October 1, 2005, EGRP no longer sends by mail or e-mail Summary Statements
and notification of scores/percentiles. In addition, NIH has announced that
notification letters or “mailers” about the outcome of review by
the NIH Scientific Review Group (SRG) will no longer be sent beginning February
1, 2006. Applicant organizations and Principal Investigators
are to access these documents through NIH’s Electronic Resource Administration
(eRA) Commons. Note that your organization must be registered before individual
investigators can register.
For further information, see NIH Guide Notice (NOT-OD-05-075)
Career Development Opportunities
ASCO Career Development Award
The American Society for Clinical Oncology (ASCO) Foundation offers a Career
Development Award for which the next application deadline is November
9, 2005.
This grant program provides funds to clinical investigators who have received
their initial faculty appointment to establish an independent clinical
cancer research program. The Foundation supports submissions in all oncology
subspecialties and in all emerging disciplines. Funding is for $170,000
over three years to establish an independent clinical research program.
For further information, refer to ASCO’s
Web page.
AACR Pancreatic Cancer Career Development Awards
The application deadline for the American Association for Cancer Research’s
(AACR) Career Development Awards is December 1, 2005.
The awards are for 2-year grants of $50,000 per year for direct research
expenses. They provide important transitional support as investigators
move from postdoctoral studies to faculty status.
Two awards focus on pancreatic cancer and may be of particular
interest to epidemiologists:
- AACR-PanCAN Michael Landon Career Development Award for Pancreatic
Cancer Research. Candidates must be affiliated with an institution
in the U.S. Research projects must have 100% applicability to pancreatic
cancer. The grant terms begin: July 1, 2006.
- AACR-Barletta Foundation Career Development
Award for Translational Pancreatic Cancer Research. Research projects
are restricted to translational cancer research with 100% applicability
to pancreatic cancer, include use of human tissue, and have implications
for patient application.
For further information, access AACR’s Web site.
NIH Educational Loan Repayment Program for Health Disparities Research
NIH’s National Center on Minority
Health and Health Disparities (NCMHD)
sponsors an educational loan repayment program for which the deadline is December
1, 2005. The program provides for repayment of educational
loan debt of up to $35,000 annually for qualified health professionals conducting
minority health or other health disparities research for domestic non-profit
or government entities. Payments equal to 39 percent of the loan repayments
are issued to the Internal Revenue Service on behalf of the program participants
to offset Federal tax liabilities incurred as a result of participating in
the program. The program may also provide reimbursement for state and local
tax liabilities.
Qualified health professionals are invited to apply who contractually agree
to engage in minority health or other health disparities research for at least
two years, and who agree to engage in this area of research for at least 50
percent of their work schedule (not less than 20 hours per week based on a
40-hour work week.
More further information, refer to NIH Guide Notice
(NOT-MD-05-005).
Applications must be submitted via the NIH
Loan Repayment Web site.
Direct questions by e-mail: lrp@nih.gov,
or telephone the LRP helpline: 866-849-4047, or the NCMHD Loan Repayment
Program Coordinator: 301-402-1366.
Access information about other NIH Educational
Loan Repayment Programs.
NIH Center for Scientific Review
Offers Internship Program
NIH’s Center for Scientific Review (CSR) offers a Review Internship
Program that provides 1 to 2 years of full-time training within CSR to
biomedical and behavioral research scientists interested in careers in science
administration. CSR manages the peer review groups (study sections) that
evaluate the vast majority of investigator-initiated grant applications submitted
to NIH.
Interns work with a diverse and dedicated group of scientists in their
fields and help conduct state-of-the-art scientific review meetings. They
are mentored by an experienced Scientific Review Administer (SRA) and receive
hands-on experience in managing a small study section or Special Emphasis
Panel, recruiting scientific peer reviewers, editing Summary Statements.
Applicants must be researchers with a Ph.D. or other professional degree
and have at least 4 years of post-doctoral scientific experience. U.S.
citizenship is not required, but non-citizens must obtain an appropriate
visa.
Apply by January 3, 2006 for positions starting July 2006.
For further information, contact Ms. Mary Elizabeth Mason, tel.: 301- 435-1114;
e-mail: masonm@csr.nih.gov.
TTY-TDD users may call Ms. Lori Stoller-Cruz, tel.: 301-594-7891; e-mail: stollerl@csr.nih.gov
NIH Town Hall Meeting on Kirschstein Awards Tuition, Fees, and Health Insurance
Policies: Statements due November 4, 2005
NIH will hold a Town Hall meeting on November 30, 2005, to hear comments and
insights about possible revisions to certain fiscal policies that govern the
Ruth L. Kirschstein National Research Service Awards (NRSA), which comprise
institutional training grants (T32, T34) and individual fellowships (F30, F31,
F32, F33). This open public meeting will focus primarily on the funding of
educational costs such as tuition, fees, and health insurance provided through
institutional training grants. The meeting will be held in the Natcher Conference
Center, Room E1/E2, NIH campus, Bethesda, Md.
Those who wish to attend the meeting are invited to submit a brief
statement, not to exceed two pages, summarizing views and experiences relevant
to the topic of the meeting by November 4, 2005. Some of those submitting
statements will be asked to make brief oral presentations at the meeting.
For instructions and further information, refer to the NIH Guide Notice
NOT-OD-06-003. All individuals who wish to attend the meeting should register
through the Town Hall meeting's
Web site. Participants are responsible
for their own expenses associated with participating in this meeting, such
as for travel.
Direct inquiries Dr. Warren Jones, National Institute of General Medical Sciences
(NIGMS), tel.: 301-594-3827; e-mail: jonesw@nigms.nih.gov.
NIH K Award Recipients May Hold Concurrent Grant Support
Recipients of NIH mentored career awards – the K awards – may
hold concurrent support from their award and a competing research grant
when recognized as a Principal Investigator or a subproject director. K award
recipients who are in the last two years of their support period are permitted
to reduce the level of effort required for the career award and replace that
effort with an NIH research grant or subproject provided that they remain
in a mentored situation. This change in policy occurred a couple of years
ago, but some individuals remain unaware of the change.
For further information, refer to the NIH Guide Notice (NOT-OD-04-007).
For information about other training opportunities for cancer epidemiologists,
visit EGRP’s Training Opportunties Web
page.
EGRP Staff News
Program Director Iwamoto Retires
 With
great regret but the warmest of wishes, we’ve said goodbye to Kumiko
(Kumi) Iwamoto, M.D., Dr.P.H., Program Director with the Analytic
Epidemiology Research Branch (AERB), who retired from federal service
at the end of August. Since joining NCI in 1990 from the University of
Michigan, she worked as a program director in NCI’s extramural
epidemiology program. Dr. Iwamoto spearheaded a new extramural program
in molecular epidemiology that brought epidemiologists and laboratory
scientists together to work collaboratively, and developed initiatives
focusing on the etiology of prostate cancer.
She also played a lead role in developing initiatives to explore relationships
between environmental exposures and breast cancer in response to Congressional
mandates, including the Breast Cancer and Environment Research Centers
(BCERC), Northeast Mid-Atlantic Breast Cancer Study (NE/MA), and the Long
Island Breast Cancer Study (LIBCSP). Dr. Iwamoto is returning to Utah to
spend time with family and enjoy her retirement. She left with us and to
share with you this beautiful Utah photograph.
Program Analyst Valle Departs
 Carmina
Valle, M.P.H., who has been a Program Analyst in AERB, has taken a new
position with the Office of Cancer Survivorship (OCS), which also is part
of our Division of Cancer Control and Population Sciences (DCCPS). Before
joining EGRP full time, Valle was a Presidential Management Fellow, and among
her rotations worked with NCI’s President’s Cancer Panel as it
explored survivorship issues, the Lance Armstrong Foundation, and OCS on
some of its activities. We are sorry that she is departing but are pleased
that she remains with DCCPS.
Subscribe to EGRP Bulletins and News Flashes
You are welcome to invite others to subscribe to receive occasional Bulletins
and News Flashes from the Epidemiology and Genetics Research Program (EGRP).
To subscribe to FRIENDS-OF-NCI-EGRP-L, contact andersoL2@mail.nih.gov.
|
